Multiple Myeloma

Filter By:
When discussing multiple myeloma treatment certain terms like “MRD” or “complete response” are often mentioned. But what do these terms mean? Dr. Faith Davies from University of Arkansas Medical Sciences joins Patient Power to help us understand some of these common medical terms and phrases and what they mean for myeloma patients. Get email ale...
by:patientpower | 24 views
Prof John Gribben (Barts Cancer Institute, London, UK) chairs a discussion with Dr Wyndham Wilson (National Cancer Institute, Bethesda, USA), Prof Anton Hagenbeek (Academic Medical Center, Amsterdam, Netherlands), Prof Michael Pfreundschuh (University of Saarland, Homburg-Saar, Germany) and Dr Myron...
by:EMJ | 105 views
Patients with cancer undergoing chemotherapy and radiation may be at risk for Oral Mucositis, a condition characterized by redness, inflammation and ulcer like sores throughout the mouth and throat. Oral Mucositis can be extremely painful and may also lead to infection. The following tips can be hel...
by:DARABioSciences | 1566 views
Louis M. Weiner, MD, explains that checkpoint inhibitors represent a promising treatment option for essentially all types of cancer, since a tumor cannot form without first overcoming the immune system. To view more from this discussion, visit http://www.o...
by:onclivetv | 557 views
Jean DiCarlo-Wagner is a vibrant Stage III Colorectal Cancer Survivor turned yoga instructor. In this video, she shares her gift of teaching Yoga to cancer survivors at National Women's Survivor Convention. Jean invites you to take your shoes off, enjoy some monkey-see, monkey-do yoga and relax. Sh...
by:SayYEStoHOPE | 1217 views
Filmed at the 2014 Great Debates and Updates in Hematologic Malignancies Congress in New York, this online activity is comprised of three videos wherein Dr. James M. Epstein is joined by Drs. Robert Z. Orlowski, David P. Steensma, and John P. Leonard to discuss recent clinical advances in hematologic malignancies. This engaging conversational forma...
by:imedex | 900 views
Dr Kenneth Anderson (Dana Farber Cancer Institute, Boston, USA) chairs a discussion with Prof Gareth Morgan (The Royal Marsden Hospital, London, UK) and Prof Paul Richardson (Harvard Medical School, Boston, USA) at Myeloma 2014 about the treatment of myeloma. They discuss the trends in therapy the...
by:Myeloma2014 | 1970 views
Dr Anderson (Dana Farber Cancer Institute, Boston, USA) chairs a discussion with Prof Palumbo (University of Torina, Torina, Italy), Prof Gareth Morgan (The Royal Marsden Hospital, London, UK), and Prof San Miguel (University Hospital, Salamanca, Spain) at Myeloma 2014 about the treatment of Myeloma...
by:Myeloma2014 | 1618 views
Prof Keith Stewart (Mayo Clinic, Scottsdale, USA) chairs a discussion with Prof Gareth Morgan (The Royal Marsden Hospital, London, UK), Dr Leif L. Bergsagel (Mayo Clinic, Scottsdale, Arizona), and Prof Antonio Palumbo (University of Torina, Torina, Italy) at Myeloma 2014, about the treatment of myel...
by:Myeloma2014 | 1398 views
Dr Ola Landgren from Memorial Sloan Kettering, New York, USA, tells the European Medical Journal about the possible enormous value of minimal residual disease (MRD) monitoring in multiple myeloma (MM) as a potential new end-point in MM clinical trials, and as a marker of therapeutic response.
by:PatientPowerEU | 3004 views

Top Tags

Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Different type of MD 
Other oncology Professional 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.

username:   password: remember me

Sign In

Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)